- ongoing, recruitingTherapeutic exploratory (Phase II)
ANISE-II; ANIfrolumab treatment for 24 weeks in patients with primary Sjögren’s syndrome – Efficacy and safety assessment in a randomized, double-blind, placebo-controlled phase-IIa proof-of-concept trial
This study is testing a new medicine called Saphnelo for Sjogren's disease. Researchers want to see if it helps reduce symptoms and if it's safe over 24 weeks. Patients will either receive Saphnelo or a dummy medicine.
Netherlands - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants with Sjögren’s Disease
This study is looking at a new medicine called Abiprubart for Sjögren’s disease. It's a key step to see how well it works and if it's safe. The trial involves different doses and uses a dummy medicine for comparison.
Germany · Hungary · Czechia